Drug repositioning of disulfiram induces endometrioid epithelial ovarian cancer cell death via the both apoptosis and cuproptosis pathways
Authors:
Open Access
- 1 January 2023
- journal article
- research article
- Published by Tech Science Press in Oncology Research
- Vol. 31 (3) , 333-343
Abstract
Various therapeutic strategies have been developed to overcome ovarian cancer. However, the prognoses resulting from these strategies are still unclear. In the present work, we screened 54 small molecule compounds approved by the FDA to identify novel agents that could inhibit the viability of human epithelial ovarian cancer cells. Among these, we identified disulfiram (DSF), an old alcohol-abuse drug, as a potential inducer of cell death in ovarian cancer. Mechanistically, DSF treatment significantly reduced the expression of the anti-apoptosis marker B-cell lymphoma/leukemia-2 (Bcl-2) and increase the expression of the apoptotic molecules Bcl2 associated X (Bax) and cleaved caspase-3 to promote human epithelial ovarian cancer cell apoptosis. Furthermore, DSF is a newly identified effective copper ionophore, thus the combination of DSF and copper was used to reduce ovarian cancer viability than DSF single treatment. Combination treatment with DSF and copper also led to the reduced expression of ferredoxin 1 and loss of Fe-S cluster proteins (biomarkers of cuproptosis). In vivo, DSF and copper gluconate significantly decreased the tumor volume and increased the survival rate in a murine ovarian cancer xenograft model. Thus, the role of DSF revealed its potential for used as a viable therapeutic agent for the ovarian cancer.Keywords
This publication has 54 references indexed in Scilit:
- RETRACTED ARTICLE: Targeted immune therapy of ovarian cancerCancer and Metastasis Reviews, 2014
- Sinoporphyrin sodium, a novel sensitizer, triggers mitochondrial-dependent apoptosis in ECA-109 cells via production of reactive oxygen speciesInternational Journal of Nanomedicine, 2014
- Gallium-Containing Anticancer CompoundsFuture Medicinal Chemistry, 2012
- Rethinking ovarian cancer: recommendations for improving outcomesNature Reviews Cancer, 2011
- New uses for old copper-binding drugs: converting the pro-angiogenic copper to a specific cancer cell death inducerExpert Opinion on Therapeutic Targets, 2008
- Dual role of hydrogen peroxide in cancer: Possible relevance to cancer chemoprevention and therapyCancer Letters, 2007
- The Status of DisulfiramJournal of Clinical Psychopharmacology, 2006
- Prognostic factors in ovarian cancer: how close are we to a complete picture?Annals of Oncology, 2005
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Dithiocarbamate Toxicity toward Thymocytes Involves Their Copper-Catalyzed Conversion to Thiuram Disulfides, Which Oxidize Glutathione in a Redox Cycle without the Release of Reactive Oxygen SpeciesArchives of Biochemistry and Biophysics, 1998